Insider filing · MRNA

Stephane Bancel bought $5.0M of Moderna (MRNA)

Executed Mar 3 2025, disclosed Mar 4 2025, 1 day later.

Over the 21 trading sessions from the disclosed entry session (Mar 4 2025), the stock returned -8.8% (delay-adjusted); from the execution session (Mar 3 2025), -9.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

SB Stephane Bancel Chief Executive Officer profile →

Stephane Bancel (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Moderna, Inc. (MRNA). The largest single filing was $28.7M of MRNA (499,246 sh across 4 lots, as filed), executed Aug 5.

MRNA Moderna, Inc. MRNA · Healthcare · 18 filings in 24 months ticker →

Healthcare · Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→